Microdose GLP-1 protocols are designed to be gentler, and some patients may find them easier to tolerate
Sattar N, Lee MMY, Kristensen SL et al (2021) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
If the agency takes the panel's recommendations, clinicians could have the ability to prescribe six peptide therapies: BPC-157, MOTS-c, KPV, TB-500, Epitalon and Semax
Higher SHBG Less free testosterone available for muscle and metabolism
Zhang Q, Hu Y, Hu JE, Ding Y, Shen Y, Xu H, et al
Protein breaks down into peptides and amino acids that directly stimulate L-cells to release GLP-1